LIMNW NASDAQ
Liminatus Pharma, Inc. Warrants
1W: +27.3%
1M: -16.2%
3M: -42.6%
YTD: +52.9%
1Y: -85.8%
$0.05
+0.00 (+11.01%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-13M
Net Income
+0.0% YoY
$-4M
Free Cash Flow
+0.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-4165.9%
ROA-367.9%
ROIC252.1%
Valuation
P/E-0.2
P/B6.2
EV/EBITDA0.1
Leverage
Debt/Equity4.80
Current Ratio1.12
Interest Cov.-164.6x
Quality Scores
Piotroski F2/9
Altman Z-28.96
Beneish M0.00